Neoleukin Therapeutics Price Prediction

At this time the value of rsi of Neoleukin Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Neoleukin Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Neoleukin Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using Neoleukin Therapeutics hype-based prediction, you can estimate the value of Neoleukin Therapeutics from the perspective of Neoleukin Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Neoleukin Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Neoleukin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Neoleukin Therapeutics after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Symbol  NLTX
Name  Neoleukin Therapeutics
TypeStock
Country  
 United States
Exchange  NASDAQ

Hype Analysis is not found for Neoleukin Therapeutics at this time

We are unable to locate Neoleukin Therapeutics hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.

Hype Analysis

Prediction analysis is currently not available

Other Suggestions

NL NL IndustriesCompany
NLY-PI Annaly Capital ManagementCompany
NLCCX Voya Large Cap GrowthMutual Fund
NLR VanEck UraniumNuclear EnergyETF
NLG NLGCryptocurrency

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Neoleukin Therapeutics Additional Predictive Modules

Most predictive techniques to examine Neoleukin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neoleukin using various technical indicators. When you analyze Neoleukin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Story Coverage note for Neoleukin Therapeutics

The number of cover stories for Neoleukin Therapeutics depends on current market conditions and Neoleukin Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neoleukin Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neoleukin Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Neoleukin Therapeutics Short Properties

Neoleukin Therapeutics' future price predictability will typically decrease when Neoleukin Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neoleukin Therapeutics often depends not only on the future outlook of the potential Neoleukin Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neoleukin Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding55.2 M
Cash And Short Term Investments96.4 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Neoleukin Stock

If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges